Arbutus: Fourth Quarter Financial Results Overview
Arbutus Biopharma Corp. Reports Fourth Quarter Financial Results
Arbutus Biopharma Corp., headquartered in Warminster, Pennsylvania, announced a net loss of $3.8 million for the fourth quarter.
This translates to a loss of $0.01 per share for the period.
During the same quarter, the company generated $1.1 million in revenue.
Looking at the full year, Arbutus Biopharma reduced its annual loss to $33.5 million, or $0.17 per share, with total revenue reaching $14.1 million.
At the close of the latest trading session, the company's stock was priced at $4.24, compared to $3.28 at the same time last year.
Financial data provided by Automated Insights, utilizing information from Zacks Investment Research.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
English Proficiency: A Measurable ROI Driver in European Business


Microsoft: Is This a Stock to Steer Clear of or a Rare Buying Chance in Ten Years?

